Trial intelligence / Profile preview

Outpatient Treatment of Early COVID-19 Pneumonia With Oral Prednisone

2020-001622-64Phase 4Active

Sponsor
Ana Pueyo Bastida
Start
Apr 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of prednisone in coronavirus disease 2019 (COVID-19), sponsored by Ana Pueyo Bastida. Primary endpoint: Clinical referral events from primary care. Started Apr 2020; status: active.

02

Drugs

prednisone
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2020-001622-64.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001622-64.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call